+499.5%
MRNA vs PSKY
-26.0%
+525.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PSKY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -1.8% |
| 7D | +5.5% | -0.2% | +5.7% | +5.4% |
| 30D | +158.7% | +24.0% | +134.8% | +151.7% |
| 3M | +182.1% | +2.2% | +180.0% | +180.8% |
| 6M | +151.8% | -9.0% | +160.8% | +152.1% |
| YTD | +393.6% | -18.1% | +411.7% | +389.4% |
| 1Y | +499.5% | -25.1% | +524.6% | +511.1% |
| All | +499.5% | -26.0% | +525.5% | +511.1% |
Cumulative growth
Daily Returns
Daily percentage return beside PSKY.
Daily Out/Under-Performance
Portfolio return minus PSKY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSKY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PSKY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling